MoxiePlex Multi-spectral imaging system
The MoxiePlex Multi-spectral imaging system captures high-resolution images of entire tissue samples stained with multiple fluorescent dyes. These images support spatial proteomics workflows and accelerate translational research in drug discovery.
The MoxiePlex provides up to 9 channels of fluorescence imaging across the entire tissue section on a glass slide.
With a 16-bit output, it delivers high-resolution imaging essential for image analysis. Additionally, the system is equipped with a state-of-the-art camera featuring high quantum efficiency across a 400 nm to 900 nm wavelength range, allowing for a broader selection of fluorescent reagents and enhanced biomarker detection.
The MoxiePlex allows side-by-side visualization of brightfield and fluorescence images within the MoxiePlex software. It captures high-resolution images of H&E-stained, immunohistochemically (IHC)-stained, and specially stained samples, providing a comprehensive view of tissue morphology for in-depth observation and analysis.
H&E
IHC
The MoxiePlex uses proprietary fluorescence optics technology and algorithms to automate sample recognition, scan range setting, focus position setting, and exposure time calculation. This not only reduces the manual workload required for setup, but also improves reproducibility when performing repeated measurements under the same conditions. Users can choose between fully automated operation to minimize manual effort or manual adjustments for greater flexibility and control. Furthermore, unmixing processing can be performed simultaneously with scanning, enabling efficient transition from data acquisition to analysis.
In MoxiePlex, the entire tissue sample is first imaged using low magnification and a wide field of view prior to scanning.
Based on these images, the system automatically detects the sample, adjusts exposure time, and determines optimal focus positions, enabling automation of processes that traditionally required manual adjustment. (Patent pending)
Unmixing in multiplex fluorescence staining is an analytical method that separates overlapping fluorescence signals into their individual components.
By applying unmixing techniques, MoxiePlex enables accurate extraction of target fluorophore signals while maintaining quantitative fluorescence intensity, even in multiplex-stained samples where spectral overlap and crosstalk are prevalent.
Additionally, this approach reduces autofluorescence components with broad emission spectra, such as those originating from red blood cells, contributing to improved signal separation performance and enhanced analytical accuracy in multiplex fluorescence analysis.
MoxiePlex is equipped with a library creation function that enables the generation of libraries used for unmixing from pre-acquired images of single-stained samples.
In addition, for samples exhibiting autofluorescence, libraries including autofluorescence components can also be created, enabling more accurate unmixing analysis.
The system also allows flexible updating of libraries in response to changes in assay conditions or imaging systems, helping to reduce operational costs and processing time associated with unmixing analysis.
MoxiePlex library creation workflow
This article is an interview published on the website of the world‑renowned scientific journal Nature. In this discussion, three experts—Dr. Carlo Bifulco (Providence Genomics), Dr. David Rimm (Yale University), and Don Ariyakumar (HAMAMATSU CORPORATION)—share their perspectives on the clinical application of spatial proteomics technologies, which enable detailed analysis of proteins within cancer cells and their surrounding microenvironment. They also discuss the unique features of MoxiePlex and its contributions to diagnostics and therapeutic decision‑making.
The SITC 2025 session, “From Spatial Biology to Clinical Utility: Advancing Lung Cancer Diagnostics,” explores cutting-edge advancements in spatial biology technologies and their transformative potential in improving lung cancer diagnosis and treatment strategies. The discussion features insights from Dr. Carlo Bifulco, Chief Medical Officer at Providence Genomics and Director of Translational Molecular Pathology at EACRI, and Xiaoshan Wang, VP of Business Development for Spatomics, and who share perspectives from both industry and clinical research.
From 1:40|Maximizing Diagnostic Power from Limited Lung Cancer Tissue
Carlo Bifulco, MD – Chief Medical Officer at Providence Genomics | Director of Translational Molecular Pathology at the Earle A Chiles Research Institute
From 34:43|Breaking the Multiplex Barrier with CFP™ Cleavable Tyramide Technology
Xiaoshan Wang – Spatomics
| Product name | MoxiePlex Multi-spectral imaging system | |
|---|---|---|
| Product number | C16919-01 | |
| Cassette loader | Up to 60 slides | |
| Compatible glass slide | 75.0 mm to 76.0 mm × 25.0 mm to 26.0 mm (Thickness: 0.9 mm to 1.2 mm) |
|
| Objective lens | 20× NA 0.8 |
|
| Scanning resolution | 20x mode | 0.46 μm/pixel |
| 40x mode | 0.23 μm/pixel | |
| Brightfield scan speed | 20x mode | Approx. 60 s(15 mm × 15 mm) |
| 40x mode | Approx. 70 s(15 mm × 15 mm) | |
| Fluorescence throughput *1 | 20x mode | Approx. 12 min.(15 mm × 15 mm, 5 channels) |
| 40x mode | Approx. 14 min.(15 mm × 15 mm, 5 channels) | |
| Fluorescence camera | In-house CMOS camera | |
| Z-stack feature | Included | |
| Image format | OME-TIFF (16 bit, 8 bit), NDPI (8 bit) | |
| Power supply | AC 100 V to AC 240 V | |
| Power consumption | Approx. 180 VA | |
*1 Fluorescence throughput: The time from loading the glass slide, macro photography, prefocusing 5 points, scanning, image processing, to unloading the glass slide.
It looks like you're in the . If this is not your location, please select the correct region or country below.
You're headed to Hamamatsu Photonics website for US (English). If you want to view an other country's site, the optimized information will be provided by selecting options below.
In order to use this website comfortably, we use cookies. For cookie details please see our cookie policy.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in this cookie policy. By closing the cookie warning banner, scrolling the page, clicking a link or continuing to browse otherwise, you agree to the use of cookies.
Hamamatsu uses cookies in order to enhance your experience on our website and ensure that our website functions.
You can visit this page at any time to learn more about cookies, get the most up to date information on how we use cookies and manage your cookie settings. We will not use cookies for any purpose other than the ones stated, but please note that we reserve the right to update our cookies.
For modern websites to work according to visitor’s expectations, they need to collect certain basic information about visitors. To do this, a site will create small text files which are placed on visitor’s devices (computer or mobile) - these files are known as cookies when you access a website. Cookies are used in order to make websites function and work efficiently. Cookies are uniquely assigned to each visitor and can only be read by a web server in the domain that issued the cookie to the visitor. Cookies cannot be used to run programs or deliver viruses to a visitor’s device.
Cookies do various jobs which make the visitor’s experience of the internet much smoother and more interactive. For instance, cookies are used to remember the visitor’s preferences on sites they visit often, to remember language preference and to help navigate between pages more efficiently. Much, though not all, of the data collected is anonymous, though some of it is designed to detect browsing patterns and approximate geographical location to improve the visitor experience.
Certain type of cookies may require the data subject’s consent before storing them on the computer.
This website uses two types of cookies:
This website uses cookies for following purposes:
Cookies help us help you. Through the use of cookies, we learn what is important to our visitors and we develop and enhance website content and functionality to support your experience. Much of our website can be accessed if cookies are disabled, however certain website functions may not work. And, we believe your current and future visits will be enhanced if cookies are enabled.
There are two ways to manage cookie preferences.
If you don’t want to receive cookies, you can modify your browser so that it notifies you when cookies are sent to it or you can refuse cookies altogether. You can also delete cookies that have already been set.
If you wish to restrict or block web browser cookies which are set on your device then you can do this through your browser settings; the Help function within your browser should tell you how. Alternatively, you may wish to visit www.aboutcookies.org, which contains comprehensive information on how to do this on a wide variety of desktop browsers.
Occasionally, we may use internet tags (also known as action tags, single-pixel GIFs, clear GIFs, invisible GIFs and 1-by-1 GIFs) at this site and may deploy these tags/cookies through a third-party advertising partner or a web analytical service partner which may be located and store the respective information (including your IP-address) in a foreign country. These tags/cookies are placed on both online advertisements that bring users to this site and on different pages of this site. We use this technology to measure the visitors' responses to our sites and the effectiveness of our advertising campaigns (including how many times a page is opened and which information is consulted) as well as to evaluate your use of this website. The third-party partner or the web analytical service partner may be able to collect data about visitors to our and other sites because of these internet tags/cookies, may compose reports regarding the website’s activity for us and may provide further services which are related to the use of the website and the internet. They may provide such information to other parties if there is a legal requirement that they do so, or if they hire the other parties to process information on their behalf.
If you would like more information about web tags and cookies associated with on-line advertising or to opt-out of third-party collection of this information, please visit the Network Advertising Initiative website http://www.networkadvertising.org.
We use third-party cookies (such as Google Analytics) to track visitors on our website, to get reports about how visitors use the website and to inform, optimize and serve ads based on someone's past visits to our website.
You may opt-out of Google Analytics cookies by the websites provided by Google:
https://tools.google.com/dlpage/gaoptout?hl=en
As provided in this Privacy Policy (Article 5), you can learn more about opt-out cookies by the website provided by Network Advertising Initiative:
http://www.networkadvertising.org
We inform you that in such case you will not be able to wholly use all functions of our website.
Close